MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with P

Paricalcitol

Paricalcitol 1microgram capsules

Use with caution

Stability notes for Paricalcitol 1microgram capsules

Store in airtight containers.

Provenance

Compatibility recommendation derived from Zemplar 1microgram capsules (AbbVie Ltd).

Supplier

Zemplar 1microgram capsules (AbbVie Ltd)

Paricalcitol 2microgram capsules

Use with caution

Stability notes for Paricalcitol 2microgram capsules

Store in airtight containers.

Provenance

Compatibility recommendation derived from Zemplar 2microgram capulsts (AbbVie Ltd).

Supplier

Zemplar 2microgram capsules (AbbVie Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.